search
Back to results

Sweetened Beverages and Food Intake

Primary Purpose

Overweight, Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fructose
glucose
non-caloric sweetener
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Overweight focused on measuring Overweight, Obesity, Appetite, Dietary sugars, Fructose, Glucose, Leptin, Insulin, Ghrelin

Eligibility Criteria

18 Years - 25 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age: 18-25 years
  • Body mass index: 20-25 kg/m2
  • Weight stable to within 5 pounds for 6 months prior to entering the study
  • Within 10 pounds of their lifetime maximum weight
  • Ability to be admitted for 5 hours to the General Clinical Research Center of the University of Washington on three occasions
  • Ability to provide informed written consent
  • Willingness to consume only food provided by the Nutrition Research Kitchen of the University of Washington General Clinical Research Center for three periods of 8 days each

Exclusion Criteria:

  • History of cardiovascular disease
  • Presence of diabetes mellitus or impaired glucose tolerance (fasting glucose > 100 mg/dL)
  • Presence of hypertension (blood pressure systolic/diastolic higher than 140/90)
  • Presence of phenylketonuria
  • Presence of fructose malabsorption or hereditary fructose intolerance
  • Presence of another chronic or psychiatric illness
  • Use of anabolic steroids, glucocorticoids, warfarin, beta-blockers, antidepressants, or lipid-lowering agents
  • Use of antibiotic drugs within 3 months of enrollment into the study
  • Use of tobacco products
  • Pregnancy or female subject not using contraception
  • Regular intense exercise (> 3 hour per week)
  • Vegetarian or extreme dietary preferences
  • Alcohol consumption of more than 2 drinks per day
  • Presence of eating disorder
  • History of frequent attempts at weight loss
  • Currently dieting or in a weight control program
  • Recent blood donation or enrolled in other research which requires blood sampling
  • Presence or history of anemia

Sites / Locations

  • University of Washington General Clinical Research Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

1

2

3

Arm Description

Fructose-sweetened beverage Subjects will be asked to drink 4 servings of a beverage sweetened with 100% fructose per day for 8 days, while consuming an ad libitum diet (same solid food for all three diet periods).

Glucose-sweetened beverage Subjects will be asked to drink 4 servings of a beverage sweetened with 100% glucose per day for 8 days, while consuming an ad libitum diet (same solid food for all three diet periods).

Beverage sweetened with a non-caloric sweetener Subjects will be asked to drink 4 servings of a beverage sweetened with a non-caloric sweetener per day for 8 days, while consuming an ad libitum diet (same solid food for all three diet periods).

Outcomes

Primary Outcome Measures

Total energy consumed in the three diet periods.

Secondary Outcome Measures

Resting energy expenditure
Resting energy expenditure, as measured by indirect calorimetry.
Fasting and postprandial plasma concentrations of satiety and adiposity signals.
We will measure the fasting plasma concentration of leptin, adiponectin, ghrelin, insulin, glucagon-like peptide 1 (GLP-1), peptide YY (PYY), cholecystokinin (CCK), amylin, and oxyntomodulin, and the change in these endpoints in the two ours after a standardized meal has been consumed.
Fasting and postprandial plasma lipid and lipoprotein concentrations.
We will measure the fasting plasma concentrations of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and free fatty acids, as well as the changes in these endpoints in the two hours following a standardized meal. We will also measure the fatty acid composition in the plasma phospholipids, and the free fatty acid fraction of plasma.
Fasting plasma concentrations of inflammatory mediators.
We will measure the fasting plasma concentrations of C-reactive protein (high sensitivity assay), interleukin-6 (IL-6), and the soluble tumor necrosis factor alpha receptors I & II.

Full Information

First Posted
May 16, 2007
Last Updated
April 30, 2012
Sponsor
University of Washington
Collaborators
Seattle Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00475475
Brief Title
Sweetened Beverages and Food Intake
Official Title
Sweetened Beverages and Food Intake
Study Type
Interventional

2. Study Status

Record Verification Date
April 2012
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
December 2011 (Actual)
Study Completion Date
December 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
Seattle Children's Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate whether beverages sweetened with fructose promote overconsumption of calories as compared to beverages sweetened with glucose or a non-caloric sweetener.
Detailed Description
The rise in the prevalence of obesity and type 2 diabetes mellitus has been linked to an increased consumption of sugar- and particularly fructose-sweetened beverages. Preliminary evidence suggests that this could be partly explained by the fact that the reduction in the intake of solid food is inadequate to compensate for additional energy taken up from these beverages. In addition, the type of sugar used to sweeten a beverage might have a considerable impact on the body's ability to adjust food intake properly. In particular, the consumption of fructose has been reported to reduce diurnal plasma glucose, insulin, and leptin concentrations, but increase diurnal ghrelin concentrations as compared to isocaloric amounts of glucose. As the plasma concentrations of glucose, insulin, leptin, and ghrelin are involved in the regulation of food intake and energy expenditure, this might impair the longer-term ability of the body to match food intake and energy expenditure to stabilize body weight. To investigate whether the regular consumption of fructose-sweetened beverages leads to an increase in total energy intake, the investigators will enroll healthy normal-weight subjects into a controlled diet study using a double-blind randomized cross-over design. Each subject will complete three diet periods: solid food plus a beverage sweetened with fructose (A), solid food plus a beverage sweetened with glucose (B), solid food plus a beverage sweetened with a non-caloric sweetener (C). During each period, subjects will be provided with all their food for 8 days. These diets will consist of meals freshly prepared using regular food items typically found in the American diet. Solid food will be provided in excess of what the subjects are estimated to require. Subjects will be asked to eat as much of this food as they need to feel comfortably satiated, and to return all excess foods to the Nutrition Research Kitchen of the University of Washington (UW) General Clinical Research Center (GCRC). This returned food will be weighed to assess precisely the amount and type of food eaten by the subjects on each day of these diet periods. In addition to this solid food, subjects will be asked to drink a certain amount of a lemonade sweetened with either fructose (A), glucose (B), or a non-caloric sweetener (C). In groups A and B, the subjects will consume 25% of their estimated daily calorie requirement in the form of these sugar sweetened beverages, while the drink in period C will be of the same volume. Subjects will be admitted to the GCRC on the morning of day 9 of each diet period for the measurement of resting metabolic rate by means of indirect calorimetry and blood draws for the measurement of fasting plasma concentrations of adipogenic hormones and plasma lipids. Furthermore, we will administer a standardized breakfast and draw blood before and 0, 15, 30, 60, 90, and 120 minutes after this meal to measure the postprandial plasma concentrations of insulin, ghrelin, and satiety signals. Following the last postprandial blood draw, we will serve another meal to measure ad libitum food intake. Our hypothesis is that subjects will have more appetite and consume more food after they have consumed the fructose-sweetened beverage for 8 days. Primary outcome measures of this study will be the total energy consumed during the periods A, B, and C; the reduction in the intake of solid foods in periods A and B as compared to period C; and energy uptake during the ad libitum meal served on day 9 of each diet period. Secondary outcome measures will be resting energy expenditure and plasma concentrations of satiety and adiposity signals.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight, Obesity
Keywords
Overweight, Obesity, Appetite, Dietary sugars, Fructose, Glucose, Leptin, Insulin, Ghrelin

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Fructose-sweetened beverage Subjects will be asked to drink 4 servings of a beverage sweetened with 100% fructose per day for 8 days, while consuming an ad libitum diet (same solid food for all three diet periods).
Arm Title
2
Arm Type
Experimental
Arm Description
Glucose-sweetened beverage Subjects will be asked to drink 4 servings of a beverage sweetened with 100% glucose per day for 8 days, while consuming an ad libitum diet (same solid food for all three diet periods).
Arm Title
3
Arm Type
Placebo Comparator
Arm Description
Beverage sweetened with a non-caloric sweetener Subjects will be asked to drink 4 servings of a beverage sweetened with a non-caloric sweetener per day for 8 days, while consuming an ad libitum diet (same solid food for all three diet periods).
Intervention Type
Behavioral
Intervention Name(s)
Fructose
Intervention Description
25% of energy intake in the form of a fructose-sweetened beverage (arm 1), a glucose-sweetened beverage (arm 2), or an isovolumetric amount of a beverage sweetened with a non-caloric sweetener
Intervention Type
Behavioral
Intervention Name(s)
glucose
Intervention Description
25% of energy intake in the form of a fructose-sweetened beverage (arm 1), a glucose-sweetened beverage (arm 2), or an isovolumetric amount of a beverage sweetened with a non-caloric sweetener
Intervention Type
Behavioral
Intervention Name(s)
non-caloric sweetener
Intervention Description
25% of energy intake in the form of a fructose-sweetened beverage (arm 1), a glucose-sweetened beverage (arm 2), or an isovolumetric amount of a beverage sweetened with a non-caloric sweetener
Primary Outcome Measure Information:
Title
Total energy consumed in the three diet periods.
Time Frame
8 days in each period
Secondary Outcome Measure Information:
Title
Resting energy expenditure
Description
Resting energy expenditure, as measured by indirect calorimetry.
Time Frame
After 8 days of each dietary phase
Title
Fasting and postprandial plasma concentrations of satiety and adiposity signals.
Description
We will measure the fasting plasma concentration of leptin, adiponectin, ghrelin, insulin, glucagon-like peptide 1 (GLP-1), peptide YY (PYY), cholecystokinin (CCK), amylin, and oxyntomodulin, and the change in these endpoints in the two ours after a standardized meal has been consumed.
Time Frame
After 8 days of each dietary phase
Title
Fasting and postprandial plasma lipid and lipoprotein concentrations.
Description
We will measure the fasting plasma concentrations of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and free fatty acids, as well as the changes in these endpoints in the two hours following a standardized meal. We will also measure the fatty acid composition in the plasma phospholipids, and the free fatty acid fraction of plasma.
Time Frame
After 8 days of each dietary phase
Title
Fasting plasma concentrations of inflammatory mediators.
Description
We will measure the fasting plasma concentrations of C-reactive protein (high sensitivity assay), interleukin-6 (IL-6), and the soluble tumor necrosis factor alpha receptors I & II.
Time Frame
After 8 days of each dietary phase

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age: 18-25 years Body mass index: 20-25 kg/m2 Weight stable to within 5 pounds for 6 months prior to entering the study Within 10 pounds of their lifetime maximum weight Ability to be admitted for 5 hours to the General Clinical Research Center of the University of Washington on three occasions Ability to provide informed written consent Willingness to consume only food provided by the Nutrition Research Kitchen of the University of Washington General Clinical Research Center for three periods of 8 days each Exclusion Criteria: History of cardiovascular disease Presence of diabetes mellitus or impaired glucose tolerance (fasting glucose > 100 mg/dL) Presence of hypertension (blood pressure systolic/diastolic higher than 140/90) Presence of phenylketonuria Presence of fructose malabsorption or hereditary fructose intolerance Presence of another chronic or psychiatric illness Use of anabolic steroids, glucocorticoids, warfarin, beta-blockers, antidepressants, or lipid-lowering agents Use of antibiotic drugs within 3 months of enrollment into the study Use of tobacco products Pregnancy or female subject not using contraception Regular intense exercise (> 3 hour per week) Vegetarian or extreme dietary preferences Alcohol consumption of more than 2 drinks per day Presence of eating disorder History of frequent attempts at weight loss Currently dieting or in a weight control program Recent blood donation or enrolled in other research which requires blood sampling Presence or history of anemia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mario Kratz, Ph.D.
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Washington General Clinical Research Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
26537945
Citation
Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Callahan HS, Weigle DS, Kratz M. No difference in ad libitum energy intake in healthy men and women consuming beverages sweetened with fructose, glucose, or high-fructose corn syrup: a randomized trial. Am J Clin Nutr. 2015 Dec;102(6):1373-80. doi: 10.3945/ajcn.115.116368. Epub 2015 Nov 4.
Results Reference
derived

Learn more about this trial

Sweetened Beverages and Food Intake

We'll reach out to this number within 24 hrs